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During spinal cord development, Notch signalling regulates both the 
maintenance of progenitors and neuronal specification. In most spinal cord domains, a 
single Notch ligand is expressed however in the V2 domain two ligands (Dll1 and Dll4) 
are expressed. It is not known how Dll4 expression is regulated and how Dll4-mediated 
Notch signalling has a role in the specification of V2 interneurons (V2a, V2b and V2c) 
that are generated from V2 progenitors. 
To investigate how Dll4 expression is regulated, we have focused on three 
proneural bHLH genes (Mash1, Ngn1 and Ngn2), expressed in V2 progenitor cells. We 
characterized Dll4-expressing cells, by double RNA in-situ hybridization with each of 
the proneural genes. Our results revealed that Dll4+ cells can coexpress all three 
proneural genes but to different extents. Next, we have overexpressed each proneural 
gene (singly and in combination) in the chick neural tube, using in ovo electroporation. 
Embryos were tested in terms of: Dll4 expression and V2 cell-type specification. 
Although electroporation of either Mash1 or Ngn1 leads to downregulation of 
Dll4 expression in the V2 domain, only NGN1 is capable of inducing ectopic Dll4 
expression. Moreover, both double electroporation of Mash1 and Ngn1, or Mash1 and 
Ngn2, represses Dll4 expression in the V2 domain, while leading to ectopic expression 
in other ventral spinal cord domains.  
Concerning cell-type specification, electroporation of Mash1 represses both V2a 
and V2b cell fate. Electroporation of either Ngn1 or Ngn2 increases the number of V2a 
INs, while repressing V2b INs. Double electroporation of Mash1/Ngn1, Mash1/Ngn2 or 
Ngn1/Ngn2 increases the number of V2a INs and represses V2b fate. 
Together, the results presented in this thesis show that MASH1 and NGN1 can 
repress Dll4 expression and that this repression correlates with alterations in V2 IN 
specification. Our results indicate that NGN2 can affect V2 specification, although it 
does not regulate Dll4 expression. 
 
 Neurogenesis, Spinal Cord, V2 domain, Notch Signalling, Delta-like 4, 
Proneural Proteins. 
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Um dos mais complexos sistemas biológicos é o Sistema Nervoso Central que 
é constituído por um elevado número e variedade de células, como neurónios e 
células da glia. Estas células são produzidas durante o desenvolvimento embrionário 
no momento e posição correctos de modo a interagirem entre si e formarem circuitos 
funcionais. Durante o desenvolvimento embrionário da espinal medula, vários 
interneurónios excitatórios e inibitórios são gerados, sendo o balanço entre eles 
estritamente regulado. No entanto os mecanismos moleculares subjacentes a esta 
diversidade celular ainda não são totalmente conhecidos. 
A via de sinalização Notch desempenha um papel essencial durante o 
desenvolvimento do Sistema Nervoso Central. Esta via de sinalização é um sistema de 
comunicação célula-a-célula, de contacto directo entre duas células vizinhas, através 
de duas proteínas membranares: o receptor Notch e os seus ligandos (Delta, Serrate 
ou Lag-2, dependendo do organismo). Sempre que um ligando de uma célula se liga 
ao receptor de outra célula, uma série de clivagens proteolíticas são desencadeadas, 
o que, em última instância, leva à libertação do domínio intracelular do receptor Notch 
(NICD). O NICD é translocado para o núcleo onde se associa ao CSL e ao 
Mastermind, activando a transcrição de genes alvo, como os genes HES. Na ausência 
de NICD, a proteína CSL actua como repressor transcricional dos mesmos genes. 
Uma das funções da via de sinalização Notch é a capacidade de manutenção 
de progenitores neurais, durante a neurogénese, impedindo uma diferenciação 
prematura massiva de todos os progenitores. A decisão de uma célula permanecer 
como progenitor, ou de se diferenciar, é controlada pelo balanço de dois tipos de 
factores de transcrição: as proteínas proneurais, que promovem a diferenciação; e as 
proteínas HES, que reprimem a diferenciação neural. Uma célula que, 
estocasticamente expresse elevados níveis de proteínas proneurais vai diferenciar-se. 
Normalmente as proteínas proneurais activam a expressão dos ligandos do Notch, o 
que leva a que esta célula expresse elevados níveis de ligandos, activando a via de 
sinalização Notch nas células vizinhas. Esta activação leva à expressão de elevados 
níveis de proteínas HES, sendo que estas células são mantidas como progenitores. 
Assim, a célula que expressa o ligando diferencia-se em neurónio mas 
simultaneamente assegura que as células vizinhas se mantenham como progenitores. 
Visto que a neurogénese ocorre durante uma larga janela temporal, a manutenção de 
uma população de progenitores permite que estas células sejam expostas a diferentes 
estímulos e, como tal, se diferenciem em diferentes neurónios durante o 
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desenvolvimento, assegurando uma grande variedade celular ao nível do Sistema 
Nervoso Central. 
A espinal medula, ao longo do seu eixo dorso-ventral, pode ser dividida em 
onze domínios molecularmente distintos (seis deles dorsais e cinco ventrais). Estudos 
recentes mostram que a via de sinalização Notch está envolvida na especificação de 
células neurais, nomeadamente de interneurónios no domínio V2 da espinal medula. 
Neste domínio, três tipos de interneurónios diferentes: V2a, V2b e V2c, são gerados a 
partir de progenitores comuns. Na ausência da sinalização Notch, apenas os 
interneurónios V2a são gerados, o que significa que a sinalização Notch é necessária 
para a produção dos interneurónios V2b. Os interneurónios V2c foram recentemente 
identificados. Curiosamente, nesta fase do desenvolvimento, este é o único domínio 
onde se sabe que diferentes interneurónios são simultaneamente produzidos e o único 
domínio onde dois ligandos da via Notch são expressos: Dll1 e Dll4. Isto é uma 
excepção ao que ocorre em todos os outros domínios da espinal medula, onde apenas 
um ligando da via Notch é suficiente para regular a neurogénese. Possivelmente o 
ligando Dll1 está envolvido na activação da via Notch e consequentemente na 
manutenção de progenitores, enquanto o ligando Dll4 está envolvido na especificação 
dos interneurónios.  
Como é que a expressão de Dll4 é regulada no domínio V2 da espinal medula 
e como é que a especificação de interneurónios é controlada neste domínio são os 
principais temas investigados nesta tese. Os organismos modelo utilizados para 
estudar estas questões foram o embrião de ratinho e de galinha. 
Recorrendo à técnica de hibridação in-situ comecei por mapear a expressão de 
LFng (lunatic fringe) e Hes6 de modo a verificar de que modo a sinalização Notch via 
Dll1 ou Dll4 poderiam ser diferentes. Verifiquei que LFng é expresso em células que 
expressem Dll4 mas não em células que expressem Scl (marcador de V2b). Hes6 é 
expresso em células que expressem Dll1 ou Dll4 mas não em células Scl+, o que 
parece sugerir que, de facto, a sinalização Notch através destes dois ligandos é 
diferente. 
De modo a verificar como o Dll4 é regulado no domínio V2, foquei-me em três 
proteínas proneurais (MASH1, NGN1 e NGN2) que são expressas em progenitores do 
V2 e que, segundo abordagens bioinformáticas anteriores, são boas candidatas a 
regular a sua expressão.  
Primeiro foram caracterizadas as células que expressam Dll4 e cada um dos 
genes proneurais através de hibridações in-situ duplas. As células Dll4 podem co-
expressar os três genes proneurais testados mas a diferentes níveis. 
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Para testar se estas proteínas podem regular a expressão de Dll4, plasmídeos 
contendo os genes que codificam cada uma destas proteínas foram injectados 
(sozinhos ou em combinação) na espinal medula de embriões de galinha no estádio 
HH16-17 pela electroporação in ovo, de modo a sobre-expressar estas proteínas. 
Todos os embriões foram testados em termos de expressão de Dll4 e especificação de 
interneurónios. 
No que diz respeito à expressão de Dll4, a electroporação de Mash1 ou de 
Ngn1 leva a uma repressão de Dll4 no interior do domínio V2, mas apenas Ngn1 é 
capaz de induzir ectopicamente a expressão de Dll4. A sobreexpressão de NGN2, não 
altera a expressão endógena de Dll4, indicando que esta proteína proneural não será 
um factor importante no controlo da expressão deste gene. A electroporação dupla de 
Mash1 com Ngn1 ou de Mash1 com Ngn2 reprime também a expressão de Dll4 no 
domínio V2 mas leva à sua expressão ectópica noutros domínios ventrais da espinal 
medula. A sobreexpressão de NGN1 e NGN2 não parece afectar a expressão de Dll4 
na espinal medula. 
Visto que as proteínas proneurais controlam a especificação de neurónios 
durante o desenvolvimento de Sistema Nervoso Central, foi analisado se a 
sobreexpressão destas proteínas afectaria o número de interneurónios V2a. Após a 
sobreexpressão de MASH1, uma diminuição no número de interneurónios V2a foi 
observada, indicando que esta reprime, directa ou indirectamente, a produção destes 
interneurónios. Contrariamente e após a sobreexpressão de NGN1 ou NGN2, o 
número de interneurónios V2a aumenta, o que sugere que estas proteínas promovem 
directamente a diferenciação de interneurónios V2a. A sobreexpressão em diferentes 
combinações também leva a um aumento de interneurónios V2a no domínio V2.  
Foi ainda analisado se o número de progenitores de V2a através da análise de 
BHLHB5 e LIM3. Verifiquei que MASH1 e NGN1 reprimem o número destes 
progenitores enquanto Ngn2 não os afecta.  
Por hibridação in situ foi verificado se o número de interneurónios V2b também 
seria afectado e verifiquei que em todas as condições o número de V2b sofre uma 
diminuição, indicando que todas as proteínas proneurais reprimem, directa ou 
indirectamente a produção destes interneurónios.  
Além disto foi analisado o que acontecia à especificação DV da espinal medula 
aquando da sobreexpressão das proteínas proneurais. Para isso foi analisado o 
domínio MN que mantem interacções antagónicas com o domínio V2, através da 
expressão de OLIG2. Verificou-se que o número de células OLIG2+ aumentou quando 
MASH1 é o sobre-expressa ou quando as combinações de proneurais são sobre-
expressas. 
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Assim verificou-sei que MASH1 e NGN1 regulam a expressão de Dll4 e, 
consequentemente a especificação de interneurónios enquanto NGN2 não parece 
regular a expressão de Dll4, afectando apenas a especificação de interneurónios. 
Este estudo apresenta novas evidências sobre a função que diferentes 
proteínas proneurais têm na regulação da expressão de Dll4 e na especificação de 
interneurónios no domínio V2.  
Neurogénese, Espinal medula, Domínio V2, Sinalização Notch, 
Delta-like 4, Proteínas proneurais. 
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 The vertebrate nervous system contains a great diversity of neurons and glial 
cells interconnected to form highly complex neural networks. These cells are generated 
in the embryonic neural tube at specific time and position in order to accurately interact 
with each other and to assemble into a functional network.  
 
For the central nervous system (CNS) to be functionally assembled not only the 
balance between progenitors and differentiating neurons must be controlled but also 
the position where specific neurons are generated must be tightly regulated. 
After neural tube formation, neural progenitors acquire different fates according 
to their relative positions along the anterior-posterior (AP) and dorsal-ventral (DV) axes 
of the embryo. The neural tube will originate the brain anteriorly (from which the 
forebrain, midbrain and hindbrain will be formed) and the spinal cord posteriorly 1.  
Neural progenitors of the neural tube normally develop anterior identity and 
differentiate into forebrain neurons. While some neural progenitors along the AP axis of 
the neural tube need to be kept in an undifferentiated state in order to gradually acquire 
different identities, others will differentiate into midbrain, hindbrain and spinal cord 
neurons. The anterior secretion of retinoic acid (RA), which promotes neuronal 
differentiation, and the posterior secretion of FGF, which represses neuronal 
differentiation, by surrounding mesodermal tissues, is responsible for the generation of 
the CNS in a rostral-to-caudal sequence, allowing progenitors to gradually differentiate 
in the correct moment and position (Figure 1) 2, 3.  
Along the dorsal-ventral axis of the developing spinal cord, neural progenitors 
can be subdivided into eleven molecularly distinct domains (six dorsal and five 
ventral)4. Within each of these domains, populations of progenitor cells are defined by 
distinct combinations of transcription factors, induced by different levels of 
morphogens, namely by the bone morphogenetic proteins (BMPs) and WNT’s 
produced dorsally (either by roof plate or dorsal epidermis), and Sonic hedgehog (Shh), 
secreted ventrally by notochord and floor plate (Figure 1) 4, 5, 6, 7. These morphogens 
confer specific positional identities, activating region-specific differentiation 
programmes and, therefore, specifying the identity of neurons that derive from 
individual progenitor populations 8, 9, 10. 
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Notch signalling is one of the most conserved pathways in the regulation of 
metazoan development. It is involved in different processes like body segmentation 
(e.g. segmentation clock), skeletal development, embryonic haematopoiesis and neural 
development, including neuronal differentiation and glial determination controlling 
several biological functions such as apoptosis, cell proliferation and cell fate decisions, 
(Reviewed in 11). 
The Notch pathway is a cell-cell communication system that results from the 
interaction of surface proteins: a Notch receptor and its ligand. The Notch receptors are 
a type I transmembrane heterodimeric proteins present at the plasma membrane. 
These receptors are composed by an ectodomain called NECD (Notch Extracellular 
Domain) and a membrane bound intracellular domain, which are conserved between 
species 12. 
Notch receptors are activated by transmembrane ligands of the DSL family 
(Delta and Serrate from Drosophila and Lag-2 from C.elegans). The DSL ligands are 
type I transmembrane proteins with an extracellular domain that is conserved across 
species and an intracellular domain that present a small conservation even between 
different types of ligands 12. 
Despite being a highly conserved pathway, different organisms have different 
receptors and ligands, for example, in Drosophila, there is only one Notch receptor and 
Figure 1 - Diagram of a transverse section of the spinal cord. Different populations of 
neural progenitors acquire different fates according to their position along the dorsal-ventral 
axis. The patterning is established by gradients of Shh, secreted by the floor plate (FP) and the 
notochord (NC), and Wnts and BMPs, produced by the roof plates (RP) and the dorsal 
epidermis. The Retinoic Acid (RA) produced by the adjacent somites is also involved in the 
patterning (AP and DV) of the spinal cord. 
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two ligands (Delta and Serrate), while in chick two Notch receptors (Notch1 and 
Notch2) and four ligands (Delta1, Delta4, Serrate1 and Serrate2) have been described. 
In mammals there are four receptors (Notch1, Notch2, Notch3 and Notch4) and five 
ligands (Delta-like1 (Dll1), Delta-like3 (Dll3), Delta-like4 (Dll4), Jagged1 (Jag1) and 
Jagged2 (Jag2)) 13, 14. This thesis will focus on Dll4. 
 In this pathway a cell expressing the Notch ligand (signal-sending cell), either 
Delta or Serrate, signals to the neighbour cell, which expresses a Notch receptor 
(signal-receiving cell). Notch receptors are formed in the trans-Golgi as a result of a 
proteolytic cleavage at the site S1 (Figure 2). Whenever a ligand protein binds to the 
extracellular domain of the Notch receptor, this one undergoes successive proteolytic 
cleavages. The first cleavage occurs at the extracellular S2 site and it is mediated by 
extracellular proteases of the ADAM/TACE family. The S2 cleaved form of Notch 
receptor is then processed at the endomembrane S3 site by the γ-secretase. After the 
proteolytic cleavages there is a release of the NICD (Notch Intracellular Domain) that is 
translocated to the nucleus where it associates with a DNA-binding protein called CSL 
(in human, CBF1; in Drosophila, Suppressor of Hairless; and in C.elegans, Lag-1) and 
to Mastermind co-activator, forming a nuclear complex which recruits other factors to 
regulate the expression of its target genes (Figure 2). In the absence of NICD, the 
transcription factor CSL is part of a transcriptional repressor complex that represses 
genes containing promoters with CSL-binding sites, whereas in the presence of NICD it 
activates the transcription of the same genes (Figure 2) 11, 15,16. 
 
 
 
There are several CSL binding sites throughout the genome but the best 
described Notch transcriptional targets are genes encoding bHLH (basic Helix-loop-
helix) transcriptional repressors. These repressors include the Enhancer of Split 
(E(spl)) complex in Drosophila and the Hairy and Enhancer of Split homologues (HES) 
Figure 2 – Notch signaling pathway. 
Whenever a ligand (Delta) expressed in the 
signal-sending cell binds to the extracellular 
domain of Notch receptor in the signal-receiving 
cell, it leads to a conformational change in the 
receptor and, as a consequence three 
successive proteolytic cleavages occur (at sites 
S2, S3 and S4) mediated by TACE/ADAM  and 
γ-secretase, respectively. There is a release of 
NICD that is translocated to the nucleus where it 
associates with CSL and Mastermind, forming a 
complex that recruits other factors and activate 
the transcription of target genes.  
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or Hes-related (Hesr/Hey) families of proteins in vertebrates. All these proteins are 
bHLH-Orange (bHLH-O) as they contain a conserved amino acid sequence – Orange 
domain – located C-terminal to the bHLH domain 17, 18, 19. 
The HLH domain allows homo- and heterodimerization of these bHLH-O 
proteins, which can then exert their function by DNA-binding and transcriptional 
repression. These proteins can bind DNA in consensus sequences called E-boxes 
(CANNTG) or N-boxes (CACNAG) by their basic domain. After DNA binding, the C-
terminal motif WRPW recruits co-repressor factors, like Groucho, and this leads to the 
transcriptional repression of target genes, like proneural genes. Moreover, bHLH-O 
proteins can repress transcription by directly interact and form heterodimers with bHLH 
activator proteins, through the HLH domain, and this prevents binding of the activators 
to DNA, thereby stopping their transcriptional activity 18, 20. 
 
During CNS development, the Notch pathway has a critical role in neuronal 
differentiation and also in glial determination through different mechanisms. Regarding 
the neural tube, Notch receptors are expressed in uncommitted neural progenitor cells, 
which are arranged in a polarized neuroepithelium in the ventricular zone (VZ) 21. 
During vertebrate neurogenesis, Notch signalling has been shown to mediate 
cell fate decisions by maintaining neural progenitor identity, while supressing neuronal 
differentiation. In the vertebrate neural tube, the walls are composed by neuroepithelial 
cells that can differentiate into neurons. These neuroepithelial cells are polarized, with 
the basal region in contact with the basal lamina at the periphery of the tube, whereas 
the apical end is next to the lumen of the tube. Cells are in close contact to one another 
in the apical region by a variety of specialized junctions (e.g. tight junctions) 21. The 
neural progenitors are bound at the apical and basal surfaces of the neuroepithelium 
but their nuclei migrate along the axis of the cell accordingly to the cell cycle phase: M-
phase nuclei are at the apical side while cells in S-phase have their nuclei close to the 
basal surface. During G1 and G2 phases, the nuclei migrate between these two 
opposing positions, in a movement known as interkinetic nuclear migration. However, 
after division, each of the daughter cells either repeats or exits the cell cycle. When the 
cell exits the cell cycle, it loses the apical attachment and migrates out of the 
ventricular zone to the mantle zone (MZ) where it starts to differentiate 21, 22. 
Notch signalling can act to promote cell diversity through a process called 
lateral inhibition. In this process, a group of cells with a similar developmental potential 
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can give rise to different cell types and it ensures that two interacting cells do not 
acquire the same fate 9, 23. 
Regarding the maintenance of neural progenitors, two neighbouring cells signal 
to each other and one starts the process of neuronal differentiation while the other is 
kept as a progenitor. The decision of becoming a neuron or remaining as a neural 
progenitor is controlled by the balance between two different sets of transcription 
factors: proneural bHLH proteins, which instruct progenitors into neuronal 
differentiation, and HES proteins, which repress neuronal differentiation and therefore 
maintain cells as progenitors. Nevertheless, due to lateral inhibition, the decision of 
each neural progenitor is influenced by the fates of the neighbour cells. Neural 
progenitors in the VZ of the neural tube express proneural proteins, but stochastic 
variations in gene expression causes one cell to express higher levels of proneural 
genes and therefore start the differentiation process 24, 25. It is known that proneural 
proteins positively regulate the expression of Notch ligands, so the expression of these 
ligands will be higher in the differentiating cell (Figure 3) 26. By lateral inhibition, this cell 
will then signal to neighbouring cells expressing Notch receptors, leading to an 
increase in HES expression, which will repress proneural genes and prevent premature 
differentiation of the cells into neurons (Figure 3) 9. 
Lateral inhibition mediated by Notch signalling provides a feedback mechanism 
Figure 3 – Lateral Inhibition mechanism. Notch signalling amplifies small or weak differences 
within roughly equivalent populations of cells. Cells in the proneural cluster express proneural 
proteins.  One cell expresses higher levels of proneural proteins and start differentiating. This will 
regulate positively the expression of Delta, which by lateral inhibition causes this cell to signal to its 
neighbours (Notch
+
).Notch signalling is activated in the surrounding cells, increasing the expression 
of HES genes, which repress proneural proteins. These cells will remain as progenitor cells, while 
the other cell will differentiate. Adapted from Gilbert, 2006. 
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to control the production of neurons 23. Also it maintains a pool of neural progenitors 
throughout neurogenesis, which allow these cells to be exposed to different 
environmental cues and to differentiate into different neurons during development. 
Furthermore, as neurons and glia cells are produced from the same progenitor pool, 
the maintenance of these cells by Notch signalling allows the later production of glia 
cells, after neurogenesis 11. 
 
Notch signalling is also important in the specification of neuronal fates. Several 
studies indicate a role of Notch signalling not only in progenitor maintenance but also 
as an instructive cue to the production of glial cells 11, 27, 28. 
In the vertebrate CNS, neurons are generated before glial cells. The shift from 
neurogenesis to gliogenesis involves a decrease in gene expression required for 
neurogenesis and an increase in expression of genes required to gliogenesis 11. 
Although Notch signalling might induce the formation of glial cells, like astrocytes, it 
may also contribute to inhibition of the oligodendrocyte fate 29. 
Notch signalling is also proposed to regulated cell-type specification in ear, 
retina and spinal cord development 28, 30. In the retina, the differentiating retinal neurons 
strongly express the Notch ligand, Dll4, and it is known that Notch-Dll4 signalling is 
involved in cell-fate choice steps during retinogenesis 14. The next section of this thesis 
will focus on the spinal cord case. 
 
In the developing spinal cord, along the DV axis, there are eleven molecularly 
distinct domains in the spinal cord: six dorsal and five ventral (Figure 1) and each one 
of them express at least one Notch ligand. The most widespread ligand is Dll1, which is 
expressed in the majority of dorsal and ventral domains, being only absent in dl6 and 
V1 domains where Jag1 expression occurs 13.  However, in the V2 domain, a second 
ligand is expressed, Dll4, together with Dll1 13, 14. 
This is an exception to what seems to be a general rule exhibited in other 
domains of the developing spinal cord, where only one Notch ligand (Dll1 or Jagged1) 
is sufficient to regulate neurogenesis 13, 14. Remarkably, in the V2 domain, Dll4 is only 
expressed in a small number of cells that are starting neuronal differentiation 31. 
Another unique feature of the V2 domain is that the p2 cells (progenitor cells from the 
V2 domain) co-express different proneural bHLH proteins (MASH1, NGN1 and NGN2), 
suggesting that combinations of these transcription factors may regulate the expression 
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of Dll1 and Dll4 in this domain 32. The V2 domain is also particular as it gives rise to 
three functionally distinct classes of interneurons: V2a, V2b and V2c 33, all generated  
from a pool of molecularly similar progenitors with a specific molecular identity (e.g. 
Nkx6.1, Irx3 and Pax6) 5, 34, 35.  V2a and V2b interneurons are specified over the same 
time window but they have different physiological functions: V2a are excitatory 
glutamatergic INs, V2b are inhibitory GABAergic INs and V2c function is still unknown 
33, 36. 
Notch-Delta interactions have been suggested to play an important role in the 
initiation of a binary cell fate choice in immature V2 interneurons 30, 37, 38. Within the VZ 
of the V2 domain, cells that start the differentiation process express high levels of 
proneural proteins, and therefore high levels of Dll1, activating Notch in the 
neighbouring cells (signal-receiving cells), keeping them as progenitors (Figure 4) 32,  33. 
Some V2 cells that are committed to differentiation will express high levels of Dll4 and 
will differentiate into V2a INs (Ramos, C. et al, unpublished). These Dll4+ signal-
sending cells have been shown to downregulate Gata2 39, while maintaining the 
expression of Lim3 (LIM homeobox 3) 38, 40, 41. These cells will then downregulate Lim3 
and activate the expression of Bhlhb5 and Chx10, adopting the V2a cell fate 37, 42. The 
remaining cells committing to differentiation, do not express Dll4 and, will downregulate 
Lim3 40, while maintaining the expression of Gata2 39, and activate the expression of 
Scl (Stem cell leukaemia) and Gata3 to adopt V2b cell fate (Figure 4) 37, 42, 43.  
Even though it is known that Notch signalling is crucial in V2 cell fate 
specification, how Dll1 and Dll4 ligands mediate this process is still under study. 
Previous analyses of Dll1-mutant mice (conditional knock-out) reveal that both V2a and 
V2b INs are generated, although in different numbers (increased number of V2a INs), 
when compared to control littermates 14, 30, 42. In Notch1 mutants all V2 progenitors 
acquire V2a fate, at the expense of the V2b fate 42. Furthermore, overexpression of 
DLL4 in chick spinal cord increases the number of V2b INs at the expense of V2a INs, 
whereas overexpression of DLL1 doesn’t affect significantly the number of V2a vs. 
V2b30. These results suggest that Notch signalling is required for the generation of V2b 
Figure 4 – V2 domain of the developing spinal cord. Cells starting the differentiation process 
express high levels of proneural proteins and, therefore, high levels of Dll1. These cells activate Notch 
signalling and keep the surrounding cells as progenitors. Some of the Dll1-expressing cells will express 
Dll4 and will differentiate into V2a INs while other V2 cells receive signals through the Notch receptor 
and differentiate into V2b and V2c INs. 
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INs and that Dll1 is not the key ligand for the V2a-V2b binary switch, a decision that 
might be controlled by Dll4-mediated Notch signalling 13, 14. 
 
Proneural transcription factors contain a Helix-Loop-Helix (HLH) domain that 
allows these proteins to dimerize and, subsequently, to bind DNA through their basic 
domain. The proneural proteins were first identified in Drosophila and were divided into 
two families: the Atonal (ATO) and Achaete-scute (ASC) families (Reviewed in 9). The 
vertebrate Achaete-scute (ASC) family includes Ash1 (e.g. MASH1 in mouse, CASH1 
in chick and ZASH1 in zebrafish) and other genes that are specific for vertebrate 
classes (MASH2 in mammals, XASH3 in Xenopus and CASH4 in chick) 9. The number 
of vertebrate proteins related to Drosophila ATO family is larger, but only two of them 
(MATH1 and MATH5 in mouse) have a bHLH domain similar enough to that of ATO to 
be considered as orthologues (reviewed in 9). Other vertebrate ATO-related proteins 
can be grouped into distinct families, e.g., the Neurogenin (NGN) family, the NeuroD 
family and the Olig family 9.  
Some of the above mentioned proneural proteins are expressed in the V2 
domain, specifically MASH1, NGN1 and NGN2, making them good candidates to 
regulate neurogenesis in this domain 32. Previous data suggest that Mash1 is 
expressed in V2 progenitors but how it is involved in interneuron specification is still 
controversial: Parras et al. reported a decrease in V2a interneurons in Mash1-mutant 
mice while the opposite result is reported by Li et al. Ngn1 and Ngn2 are also 
expressed in V2 cells but how their expression might influence V2 cell fate is still under 
study. In fact, in zebrafish, expression of DeltaD (Notch ligand) in the brain and in the 
spinal cord has been shown to be regulated by NGN and ZASH1 44 and, in mouse 
spinal cord and brain, MASH1 and NGN1/2 have been reported to directly regulated 
Dll1 expression 26. The regulation of Dll4 expression during spinal cord development is 
one of the aims of this thesis. 
  
Dll4 might have an important role for interneuron specification in the V2 domain. 
Therefore, Dll4 expression must be tightly regulated for the correct number and type of 
V2 INs to be produced.  
Regulation of Dll4 expression has been extensively studied in endothelial cells, 
since Notch signalling mediated by Dll4 has been implicated in vascular growth 31. 
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Here, vascular endothelial growth factor (VEGF) induces Dll4 expression as part of a 
negative regulatory loop, in which Dll4 act as an inhibitor of vascular sprouting. Also 
Dll4 is likely to be involved in the modulation of diverse forms of pathological 
angiogenesis, like in tumour angiogenesis. The blockade of Dll4 was found to delay 
tumour growth by enhancing the abnormal vascular sprouting, characteristic of tumour 
angiogenesis 45. Arterial specification is regulated by the combinatorial function of 
Notch signalling and SoxF transcription factors, via direct transcriptional gene 
activation. Arterial Dll4 expression requires the direct binding of both RBPJ (CSL)/NICD 
and SoxF transcription factors and this occurs downstream of the action of VEGF. The 
combinatorial role may contribute to more precise spatial and temporal control of gene 
expression within the differentiating vasculature 46. In endothelial cells, the coordinated 
activation of Notch signalling produces a wave of Dll4 expression. However in the V2 
domain of the developing spinal cord, Dll4 is expressed in a salt-and-pepper pattern, 
with cells expressing high levels of Dll4 surrounded by cells that express low levels of 
this ligand. Hence, the mechanism behind Dll4 expression in the V2 domain is most 
likely different from the mechanism controlling Dll4 expression in endothelial cells.   
Due to their expression in the V2 domain, good candidates to regulate Dll4 
expression are the proneural proteins MASH1, NGN1 and NGN2. 
Published work demonstrates that, in the chick developing spinal cord, the 
proneural protein CASH1 is involved in the regulation of Dll4 expression 30. In mouse, 
Dll4 expression has been suggested to be regulated by both MASH1 and FoxN4, a 
winged-helix forkhead protein, expressed in some V2 progenitor cells 42, 47, 48. 
 
The aim of this thesis is to unravel: i) how Dll4 expression is regulated in the V2 
domain; ii) how is Dll4 biased expression involved in V2 cell type specification. 
Particularly, I investigated how the asymmetric expression of Dll4 emerges from initially 
identical progenitor cells by testing whether there is an induction of Dll4 in some V2 
cells or if is there a repression of Dll4 in some cells in the V2 domain, using in ovo 
electroporation of regulator candidates. The chicken embryo was used as a model 
organism in this approach due to its accessibility and easy handling.  
Furthermore I characterized Dll4-expressing cells and unraveled if there is a 
difference in Dll1 and Dll4-mediated Notch signaling in the V2 domain, using mouse 
embryo as a model due to its genetic tools availability.  
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For plasmid DNA transformation, 100μL of competent E. coli bacteria were 
used. Competent bacteria were first thawed on ice and then incubated with plasmid for 
20 min on ice. The mixture was heat-shocked for 45 seconds in a water bath at 42°C 
and then incubated on ice for 2 min. After adding 900μL of Super Optimal Broth (SOB) 
medium supplemented with 10mM MgCl2 and 10mM MgSO4, bacteria were incubated 
at 37°C for 1 hour, shaking. 100μL of the mixture were plated on the appropriate 
selective LB agar media and incubated at 37°C o/n.  
 Plasmid constructs were stored at -80ºC as bacterial stocks (400µl of an o/n 
grown bacterial culture carrying the plasmids and 400µl of LB containing 30% glycerol). 
For large scale preparation of plasmid DNA (200-400µg), 100mL of the selective LB 
medium was inoculated with 1mL of plasmid bacterial culture (previously grown o/n). 
Bacteria were grown at 37ºC and processed using Genopure Plasmid Midi Kit (Roche), 
according to the given instructions. 
DNA concentration was determined by spectrophotometry using the NanoDrop 
spectrophotometer (Thermo Scientific) – see details in Annex A. 
Analytical digestions were performed to confirm gene size and identity (by 
fragment profile analysis). DNA was digested for 1-2h using 5-10U of commercially 
available enzymes and respective buffers. Restriction analysis was then performed in 
1% agarose gel. 
 
 Fertilized chicken eggs were stored for a maximum of one week at 15ºC and 
incubated ate 37ºC in a humidified incubator (SMA 60) until the required developmental 
stages. 
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 Embryos were injected with plasmid DNA using capillary needles made from 
borosilicate glass capillaries. The plasmid DNA was injected in spinal cord of chicken 
embryos at HH16-18 using the Inject+Matic (Genève®) injector (1 µg/µl). Each plasmid 
DNA was co-injected and co-electroporated with mCherryNLS@pCAGGS so that the 
electroporated cells can be visualized and act as a positive control for electroporation 
efficiency. Each plasmid DNA was injected with filtrated Fast green in order to visualize 
the injected solution. Platinum electrodes were placed 4mm apart of each other and 
parallel to the neural tube and the embryos were pulsed 5 times (25V/50 ms) using the 
Electro Square Porator™ ECM830 (BTX). Embryos were incubated again and after 36 
hours were harvested and fixed in a 4% paraformaldehyde (PFA) in PBS solution at 
4ºC o/n. 
 After fixation, embryos were washed twice in PBS and then transferred to a 
15% and then 30% sucrose in PBS solution for cryoprotection. The embryos were 
embedded in a solution containing 7.5% gelatin and 15% sucrose in PBS and frozen in 
cold isopenthane (-75ºC). The frozen embryos were stored at -80ºC until sectioned in a 
cryostat (Leica CM 3050). Embryonic tissue was sectioned (12 µm) and collected on 
Superfrost® slides. 
 
 Mouse embryos, both wild-type and mutant (single and double mutants for Dll1 
and Dll4) were collected at embryonic day 11.5. For the generation of these embryos, 
males with Cre-recombinase under regulation of Nestin promoter (specifically 
expressed in neural cells) and floxed for Dll1 and/or Dll4 were crossed with floxed 
females for Dll1 and/or Dll4. Crosses were set and vaginal plugs checked routinely to 
confirm pregnancy and, when confirmed, E11.5 embryos and the corresponding yolk 
sacs were collected. Pregnant females were sacrificed and a caesarean section 
performed to collect the embryos. All animals were fed freely and housed in SPF 
facilities. Animal experiments were approved by the Animal Ethics Committee of 
Instituto de Medicina Molecular and according to National Regulations. 
 After embryo collection, the yolk sacs were denatured and digested and the 
isolated DNA was used for genotyping with PCR for the presence of Cre in a first step 
and then for Dll1 and Dll4, followed by gel electrophoresis. Embryos without Cre were 
treated and used as wild-types control embryos. Tissue embedding and preparation of 
cryostat sections was the same as for chick embryos (previously described). 
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 Several RNA antisense probes were used to perform in situ hybridization on 
whole-mount or cryostat sections of both mouse and chick embryos. Digoxigenin- 
(DIG) and Fluorescein- (FLUO) labeled RNA antisense probes were synthesized in 
vitro by T3 or T7 RNA polymerase, from several plasmid templates (see Table 2 – 
Annex A). 
 Different Plasmid DNA constructs (10µg) were linearized using 100U of the 
specific restriction enzyme in a final volume of 100 µl for 1 hour at 37ºC. After checking 
complete digestion by running 1 µl in an agarose gel 1%, DNA template was subjected 
to column purification and cleanup using Wizard Plus SV Gel and PCR Clean-up 
System (Promega). DNA was quantified (as previously described). 
 Antisense probes were produced using 1µg of linearized plasmid DNA and 20U 
of RNA polymerase (T3 or T7) with 30mM DTT, 1x DIG-NTP mix (1mM ATP, CTG, 
GTP, 0.65mM UTP and 0.35mM DIG-UTP), 40U of RNase inhibitors (Roche), 1x 
Transcription Buffer (Stratagene) and RNase-free water in a final volume of 25µl. After 
3 hours of incubation at 37ºC, the sample was precipitated by adding 20.5µl of RNase-
free water, 2µl 0.5M EDTA, 2.5µl of 8M LiCl, 150µl of 100% ethanol and 1µl of 
glycogen and incubated o/n at -20ºC. The samples were centrifuged and the 
supernatant was discarded, RNA precipitate was washed with 70% ice-cold ethanol 
and then ressuspended in 100µl of 10mM EDTA and stored at -20ºC. To check for the 
quality of the probe, 2µl were mixed with RNA loading buffer containing formamide and, 
after a denaturation step of 5 min at 70ºC, run in agarose gel along with a probe of 
known concentration. 
 Fluorescent In situ hybridization on cryostat section was done by hybridizing 
DIG- or Fluo-labelled antisense RNA probes o/n at 68ºC in a humidified chamber 
wetted in 1x salts/50% formamide. Probes were diluted (1:100) in hybridization buffer 
and denatured at 70ºC for 10 min. After o/n hybridization, sections were washed for 10 
min with pre-warmed washing solution at 68ºC to remove coverslips and then washed 
twice with the same solution and temperature for 15 min. Sections were washed three 
times for 15 min with TBST at RT and blocked with a solution of 2% blocking reagent 
and 20% heat inactivated sheep serum in TBST for more than 1 hour at RT in a 
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humidified chamber. Section were then incubated with antibodies anti-DIG AP or anti-
FLUO AP (Roche, 1:2000) o/n at 4ºC. After o/n incubation, sections were washed three 
times with TBST for 10 min and then twice with 0.1M Tris for 10 min. The staining 
reaction for AP (alkaline phosphatase) was performed using Fast Red (Roche) for 1-3h 
at 37ºC. After the development of the probe, sections were washed twice in PBS and 
incubated with the antibody that recognizes the second probe (anti-FLUO-POD, anti-
DIG-POD or anti-DNP-POD, Roche, 1:500). After 1 hour of incubation in a humidified 
chamber at RT, sections were washed with 1x TNT three times for 10 min and the 
staining reaction for POD (peroxidase) was performed using Tyramide Signal 
Amplification (1:50, TSA) for 20 min at RT. Sections were then washed four times with 
1x TNT for 5 min, counterstained with DAPI and mounted with Mowiol mounting 
medium. 
 
 Gelatin was removed from selected regions with pre-warmed PBS1x at 37ºC, 
sections were treated with H2O2 in methanol for 30 min at RT to reduce background by 
blocking endogenous peroxidases. Sections then, went through a 0.1M Glycine in 
PBS1x treatment for 10 min at RT to quench paraformaldehyde and stop cross-linking 
reactions and were permeabilized with 0.5% Triton in PBS1x for 10 min at RT. After 
this, sections were blocked with 10% Fetal Bovine Serum (FBS) in TBST for 1 hour at 
RT and then incubated with primary antibodies, previously diluted in 10% FBS in TBST, 
o/n at 4ºC in a humidified chamber. After primary antibody binding, sections were 
washed three times with TBST for 10 min at RT and incubated with secondary 
antibodies (diluted in 10% FBS in TBST) for 1 hour at RT in a humidified chamber. 
Sections were washed again three times with TBST for 10 min at RT and then 
counterstained with DAPI for 10 min. After this sections were mounted with Mowiol 
mounting medium. 
 The H2O2 pre-treatment was not performed on electroporated chick embryos 
and on mice embryos when fluorescence was to be preserved. 
 The antibodies used during this project are described in Annex A. 
 
 Images of fixed sections with fluorescence were acquired using Leica DM5000B 
microscope with a Leica DC350F digital camera. Co-expression analysis was made 
using Confocal Laser Point-Scanning Microscope – Zeiss LSM 510 META. The 
acquired images were then treated using Adobe Photoshop software or ImageJ. 
  
14 
 Cell counts were performed using Adobe Photoshop software and were 
expressed as the number of positive cells for the relevant marker, as a percentage of 
total DAPI (mean ± SD) from the electroporated or non-electroporated side of the 
neural tube. Data were analysed using the unpaired t-test to compare two data sets 
(GraphPad Prism v.6.0). Values of p<0.05 were considered significant. 
 
Note: The composition of all solutions is described in Annex A, Table 3. 
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 Within the VZ of the V2 domain, progenitors that start the differentiation process 
express high levels of Dll1, activating Notch in surrounding cells to maintain them as 
progenitors (these cells express Hes5 and LFng) 17, 49 (Fig. 5A). The Dll1-expressing 
cells can subsequentially express Dll4 and became prospective (Bhlhb5+) V2a INs, 
activating Notch in the surrounding cells that will differentiate into prospective (Scl+) 
V2b INs (Fig. 5B). Previous data from our lab showed that Dll4-expressing cells will 
differentiate into V2a INs and activate Notch signalling in neighbouring cells (Dll4- and 
Scl+) that, in turn, differentiate into V2b INs (Ramos C. et. al unpublished) (Figure 5B).  
In the developing spinal cord, the V2 domain is the only one where two Notch 
ligands are expressed (DLL1 and DLL4), therefore a question arises: Is Dll1-mediated 
Notch signalling different from Dll4-mediated Notch signalling? One hypothesis is that, 
indeed, Dll1 and Dll4-mediated Notch signalling are different due to the presence of 
LFng, a potentiator of Notch signalling 50, in signal-receiving cells. It is known that Dll1 
is keeping the surrounding cells as progenitors, which express LFng 49, however 
concerning Dll4-mediated Notch signalling, the expression of LFng have not yet been 
mapped, so our hypothesis is that LFng might be involved in Dll1-mediated Notch 
signalling but not in Dll4-mediated Notch signalling. 
To test this hypothesis, we analysed simultaneously the expression of LFng, 
Dll4 and Scl in the V2 domain of E11.5 mouse spinal cord. The results show that LFng 
is expressed in the VZ of most spinal cord domains, being only absent in the dl6 and 
V1 domains, in agreement with previous results (Fig.6 A and B). We did not observe 
cells expressing both LFng and Scl (Fig.6 A’-A’’’) indicating that LFng is not expressed 
in prospective V2b INs. However, LFng is co-expressed with Dll4+ in cells within the V2 
A B 
Figure 5 – Cell dynamics inside V2 domain. (A) - Cells that express high levels of Dll1 will keep their 
neighbours as progenitors.(B) -  Differentiating cells can express Dll4, upregulate the expression of Bhlhb5 
(prospective V2a IN marker) and became V2a INs (Chx10
+
 cell). Their neighbours (Dll4
-
 Notch
+
 cells) 
upregulate the expression of Scl (prospective V2b marker) and differentiate into V2b INs (Gata3
+
 cell). 
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progenitor domain (Fig.6 B’-B’’’ – indicated by arrow), but not in cells outside this 
region, where only Dll4 expression can be detected.  
These data point out that Notch is activated by Dll4 in Scl+ cells without LFng 
potentiator and that Dll4-mediated Notch signalling is independent of LFng  (Fig.5A). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
We next analysed the expression of Hes6, to try to correlate its expression to 
the possible differential activity of Dll1 or Dll4 ligands. Hes6 is a downstream target of 
Notch signalling, expressed in differentiating neurons, in which it functions to release 
proneural gene expression from the inhibitory effects of downstream targets of Notch 
signalling (Hes5) 51.  
To test whether Hes6 might be activated by Dll1 and/or Dll4 we analysed 
simultaneously the expression of Hes6, Dll1, Dll4 and Scl in the V2 domain of E11.5 
mouse spinal cords. Our data show that Hes6 is expressed throughout all domains of 
the spinal cord (Fig.7 A, B, C), in the VZ. However in the V2 domain, Hes6 expression 
is detected in cells located next to the lumen in the inner ventricular zone (IVZ), an 
exception to what is observed in all the other domains. Cells co-expressing both Hes6 
and Dll1 can be observed in the V2 domain (Fig.7 A’, A’’ – indicated by arrows). Hes6 
and Dll4 were also co-expressed (Fig.7 C’-C’’’ – indicated by arrows) in cells of the V2 
domain, while coexpression of Hes6 and Scl was not detected (Fig.7 D’-D’’’). This last 
* 
Figure 6 – LFng expression in the prospective V2 INs. (A-B) – LFng is expressed in the VZ 
of V2 domain, in progenitor cells. (A’) – LFng is not coexpressed with prospective V2b marker 
Scl. (A’, A’’) – magnification of the selected regions from confocal image A’. (B’) – LFng can be 
coexpressed with Dll4. In the ventricular zone, Dll4
+
 cells express also LFng (B’’ – white arrow) 
but when they migrate outside this region the co-localization of both mRNAs is no longer 
detected (B’ - indicated by asterisk). (B’, B’’) – magnification of the selected regions from 
confocal image B’. Scale bars: A, B - 50µm; A’-A’’’, B’-B’’’ - 10µm. 
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finding suggests that Hes6 is not a Dll4 target, as it is not expressed in prospective V2b 
INs (Scl-expressing cells) where Notch signalling is activated via Dll4. Another 
possibility is that Hes6 mRNA is no longer expressed when Scl expression starts. 
Concerning Dll1, it is known that cells activated through Dll1-mediated Notch signalling 
(Hes5+LFng+) can also express Hes6 17, therefore it is possible that Hes6 is a target of 
Dll1-mediated Notch signalling.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7 – Hes6 expression in the V2 domain. (A, C, D) – Hes6 is expressed in the VZ 
of V2 domain, in progenitor and differentiating cells. (B) – Schematic representation of 
activation of HES genes transcription. (A’) – Hes6 is coexpressed with Dll1 and Dll4 (C’) 
as the magnifications of the selected regions indicate (A’’, C’’, C’’’ – indicated by arrows).  
(D’) – Hes6 is not coexpressed with Scl, a marker for prospective V2b cells. (D’’, D’’’) – 
magnification of selected regions from confocal image D’.  
Scale bars: A, C, D - 50µm; A’, A’’, C’-C’’’, D’-D’’’ - 10µm. 
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 Previous results from our lab showed that several regions in the Dll4 promoter, 
conserved between mouse and chicken, contain regulatory information for Dll4 
expression. In these regions, several E-boxes are present and are putative binding 
sites for proneural proteins like MASH1 and Neurogenins (NGNs), which are therefore 
good candidates to regulate the Dll4 expression in the V2 domain. Also, it has been 
reported that Mash1, Ngn1 and Ngn2 are expressed in the V2 domain, although the 
relationship between their expression and that of Dll4 is still unclear.  
In order to see if Dll4-expressing cells also express Mash1, Ngn1 or Ngn2, 
double in-situ hybridization was performed in neural tubes of E11.5 mice embryos.  
 As previously published, Mash1 is expressed in all dorsal spinal cord domains, 
except in dl6. Ventrally, it is only expressed in V2 domain (Fig.8 A). Both Ngn1 and 
Ngn2 are expressed in all ventral domains, being absent in the dorsal most domains 
(Fig.8 C, E).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 – Characterization of Dll4
+
 cells. (A, C, E) – Mash1, Ngn1 and Ngn2 are expressed in the V2 domain.  
(B) – Mash1 is expressed in the majority of Dll4
+
 cells (white arrows). (D) – Ngn1 is also expressed in Dll4
+
 cells 
(white arrow) but some of these cells don’t express Ngn1 (asterisk). (F) – Ngn2 is the proneural less co-expressed 
with Dll4 as many Dll4
+
 cells don’t express Ngn2 (asterisk). (G) – Graphic showing the percentage of Proneural
+
 
Dll4
+
 cells as a fraction of the Dll4 population. 79% of Dll4
+
 cells are also Mash1, 39% are also Ngn1 and 17% are 
also Ngn2. Average from three different sections of five different embryos. Scale bars: A, C and E - 20µm 
(Fluorescence Microscope); B, D and F - 10µm (Confocal Microscope). 
G 
* 
* * 
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In the V2 domain, the population of Mash1+ Dll4+ cells (Fig.8 B – white arrows) 
corresponds to 79% of the total Dll4 population (Fig.8 G). Regarding Ngn1, less than 
half of Dll4+ cells co-express Ngn1 – 39% (Fig.8 D – arrow, G). Cells that express Dll4 
but do not express Ngn1 could also be identified (Fig.8 D – asterisk). When analysing 
results for Ngn2, the results show that the majority (83%) of the Dll4+ cells do not 
express Ngn2 (Fig. 8 F – asterisks) with only 17% being Ngn2+ (Fig.8 F – white arrow, 
G).  
Overall, these results indicate that the three proneural genes are expressed in 
Dll4-expressing cells but to a different extent, with Mash1 being the most co-expressed 
gene, followed by Ngn1 and finally by Ngn2. The fact that Mash1 is the proneural gene 
that shows higher co-expression with Dll4  raises the hypothesis that Mash1 is the 
major regulator of Dll4 expression, when compared to both Ngn1 and Ngn2.  
 
 To test possible role of Mash1, Ngn1 and Ngn2 in regulating Dll4 expression, 
these transcription factors were overexpressed, single or in combination, in the chick 
embryonic spinal cord, and their effect in eliciting Dll4 expression was evaluated. In 
these experiments, a plasmid encoding the CHERRY fluorescent protein was co-
electroporated with the vectors encoding proneural genes, in order to allow the 
identification of electroporated cells in the spinal cord (see Materials and Methods). 
Embryos were harvested 36 hours after electroporation and Dll4 expression analysed, 
using fluorescent in-situ hybridization 
 Two different positive controls for Dll4 probe specificity were made. It is well 
known that endothelial cells express high levels of Dll4 (Fig. 16, Annex B – white 
arrows), and our results show also strong Dll4 expression in these cells. In embryos 
electroporated with Hes6-2:VP16 (dominant-negative form of Hes6-2 protein that act as 
an activator of Dll4 expression) we observed Dll4 expression in the electroporated 
cells, accordingly to previous reports (Fig. 16, Annex B). 
 Our results show that MASH1 overexpression represses Dll4 expression in the 
V2 domain (Fig. 9 – A’, A’’, G). This repression is significant and consistent across 
different embryos (n=8, p=2.512702e-006).  
 
79% 
39% 
17% 
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Figure 9 – Dll4 expression after electroporation of Mash1, Ngn1 and Ngn2, single or in combinations. 
(A-A’’) – MASH1 represses Dll4 expression in the V2 domain. (B-B’’) – NGN1 overexpression also represses 
Dll4 in the V2 domain but it induces ectopic Dll4 expression along DV axis (White arrows). (C-C’’) – NGN2 
overexpression does not change Dll4 expression. (D-D’’) – MASH1 together with NGN1 repress Dll4 within V2 
domain while induce ectopic Dll4 expression along the DV axis of the spinal cord. (E-E’’) – MASH1 and NGN2 
also repress Dll4 expression in the V2 domain and induce it, in the electroporated cell region. (F-F’’) – Both 
NGNs overexpressed do not alter Dll4 expression in the developing spinal cord. (G) – Percentage (%) of Dll4
+
 
cells between sides of the spinal cord in each one of the conditions tested (proneurals overexpression). 
Statistical significance (*** - p-value < 0,01; ** - p-value < 0,05). In all embryos, Cherry protein was used to 
identify the electroporated side of the spinal cord and as a positive control of the electroporation efficiency (A, 
B, C, D, E, and F). Embryos were harvested 36 hours after electroporation. Scale bars: A-F’’ - 50µm 
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Overexpression of NGN1 also represses Dll4 expression in the V2 domain 
(Fig.9 – B’, B’’, G; n=8, p=0.00383657) however it induces ectopic Dll4 expression in 
other domains along the DV axis of the spinal cord (Fig. 9 – B’’, white arrows). The 
observed induction of Dll4 expression occurs mostly in a non-cell autonomous manner 
(cells next to the electroporated ones).  
Overexpression of NGN2 does not alter Dll4 expression in the V2 domain, 
neither causes ectopic expression in other domains (Fig. 9 – C-C’’’, G; n=8, p=0.89066).  
These results show that MASH1 and NGN1 are able to regulate Dll4 
expression, while NGN2 is not. 
 To test for the presence of combinatorial effects in regulation of Dll4 expression, 
MASH1, NGN1 and NGN2 were overexpressed in different combinations. 
Simultaneous overexpression of MASH1 and NGN1 causes a repression of Dll4 
expression in the V2 domain (Fig. 9 – D-D’’’, G; n=3, p=0.00356786), while inducing 
ectopic expression of Dll4, dorsally to V2, (Fig. 9 D’’’ – white arrows), in a non-cell 
autonomous manner.  
Simultaneous overexpression of MASH1 and NGN2 also represses Dll4 
expression (Fig. 9 – E-E’’’, G; n=3, p=0.0103982) while induces ectopic expression (Fig. 
9 – E’’’, white arrows).  
When both NGNs are overexpressed, there are no significant differences in the 
number of Dll4-expressing cells (Fig. 8 – F-F’’’, G), comparing both sides of the spinal 
cord (n=3, p=0.828263). 
In conclusion, our data, from simultaneous overexpression of proneural genes, 
suggest that there are no additive effects in regulation of Dll4 expression by proneural 
proteins. However NGN2 can overcome NGN1 function, as simultaneous 
overexpression of both NGNs mimics the effect of single overexpression of NGN2 - 
Dll4 expression is not altered. 
 Parras et. al and Li et. al reported that proneural proteins can affect IN 
specification inside V2 domain. To determine whether overexpression of proneural 
proteins affects V2a interneuron specification, embryos that were electroporated with 
plasmids encoding these proteins, were analysed for the expression of CHX10, a 
protein specifically expressed in V2a INs, using immunofluorescence with an 
appropriate antibody. 
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 After MASH1 overexpression, a decrease in the number of CHX10+ cells is 
observed in the electroporated side, when compared with the non-electroporated side 
of the spinal cord (Fig. 10 A-A’, G; n=8, p=6.364437e-011).  
After NGN1 or NGN2 overexpression, an increase in the number of V2a INs 
(CHX10+ cells) is observed in the electroporated side of the spinal cord (Fig. 10 B-B’ 
and C-C’, respectively). The increase of CHX10+ cells in the electroporated side were 
significant for NGN1 (n=8, p=7.425886e-011) and for NGN2 (n=8, p=5.198783e-013). 
 Overall, these observations indicate that MASH1 represses V2a IN fate 
whereas NGN1 and NGN2 promote this fate. 
Figure 10 – CHX10 expression after electroporation of Mash1, Ngn1 and Ngn2, single or in 
combinations. (A-A’’) – MASH1 overexpression leads to a decrease in the number of CHX10
+
 cells in the 
electroporated side of the spinal cord. (B-B’’) – NGN1 overexpression leads to an increase in CHX10
+
 cells in 
the electroporated side of the spinal cord. (C-C’’) – NGN2 overexpression also leads to an increase in the 
number of CHX10
+
 cells.  (D-D’’) – MASH1 together with NGN1 increases CHX10
+
 cells in the electroporated 
side of the spinal cord. (E-E’’) – MASH1 and NGN2 also increases the number of CHX10
+
 cells within the 
electroporated side. (F-F’’) – Both NGNs overexpressed increase CHX10
+ 
cells in the electroporated side of 
the spinal cord. (B’, C’, E’ and F’) – Most of the CHX10-positive cells in the electroporated side correspond to 
electroporated cells (cherry-positive cells). (G) – Percentage (%) of CHX10
+
 cells between sides of the spinal 
cord in each one of the conditions tested (proneurals overexpression). Statistical significance (*** - p-value < 
0,01). In all embryos, Cherry protein was used to identify the electroporated side of the spinal cord and as a 
positive control of the electroporation efficiency (A, B, C, D, E, and F). Embryos were harvested 36 hours after 
electroporation. Scale bars: A-F’’ - 50µm. 
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In order to dissect for the presence of combinatorial effects in regulation of IN 
specification, MASH1, NGN1 and NGN2 were overexpressed in different combinations. 
When MASH1 was overexpressed with NGN1, an increase in the number of 
CHX10+ cells is observed  in the electroporated side of the spinal cord (Fig. 10 D-D’, G; 
n=3, p=0.00347376).  
Simultaneous overexpression of MASH1 and NGN2 or NGN1 and NGN2 
increases the number of CHX10+ cells (Fig. 10 E-E and F-F’’, G). Increase of V2a INs 
in the electroporated side of the spinal cord were significant for MASH1 and NGN1 
(n=3, p=0.00384054) and for NGN1 and NGN2 (n=3, p=0.000398324). 
 These observations indicate that positive regulation by NGNs can overcome the 
repressive effects of MASH1, as simultaneous overexpression of MASH1 with NGN1 or 
NGN2 can increase the number of V2a INs. When both NGNs were electroporated the 
increase in V2a INs was not higher than in the single electroporation scenario so we 
can exclude an additive effect in regulation of V2a IN fate. 
 
 The combined expression of Lim3 and bhlhb5 was next used to identify an 
earlier stage of V2a development, before these cells express the differentiation marker 
Chx10. While Lim3 is expressed in all V2 progenitors, bhlhb5 is specifically expressed 
in V2a INs, allowing us to ask whether the increase in CHX10 V2a Ins is due to an 
increase in the number of V2 progenitors (Lim3+) that commit to V2a fate 
(Lim3+bhlhb5+) or, alternatively, to an acceleration in the differentiation of these 
progenitors. 
 To test this, combined expression of bHLHB5 and LIM3 was analysed in 
embryos electroporated with proneural genes, using immunofluorescence with the 
appropriate antibodies. 
The results show that overexpression of MASH1 results in a decrease of 
bHLHB5+LIM3+ cells (Fig.11 A-A’’, G; n=4, p= 4.339579e-010). Also in this condition, less 
bHLHB5+LIM3+ cells were detected inside the ventricular zone (Fig.11 A’’ – white 
arrow). No differences were detected regarding the total number of Bhlhb5+ cells in all 
expressing domains (dl6, V1and V2).  
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After NGN1 overexpression, a decrease in the number of bHLHB5+LIM3+ cells 
is observed (Fig.11 B-B’’,G; n=4, p= 2.847715e-005). Like in MASH1 overexpression 
condition, just a small number of BHLHB5+LIM3+ cells were detected inside the VZ 
(Fig.11 B’’ – white arrow). An increase in the number of bHLHB5+ cells were detected 
in the electroporated side of the spinal cord, across all domains where this gene is 
normally expressed. 
Figure 11 – bHLHB5 and LIM3 expression after electroporation of Mash1, Ngn1 
and Ngn2. (A-A’’) – MASH1 overexpression leads to a decrease in the number of 
bHLHB5
+
LIM3
+
 cells, inside the V2 domain. (B-B’’) – NGN1 overexpression 
decreases the number of these double
+
 cells. (C-C’’) – NGN2 does not alter the 
number of bHLHB5
+
LIM3
+
 cells in the electroporated side of the spinal cord. (D) - % 
of bHLHB5
+
LIM3
+
 cells between sides of the spinal cord in each one of the 
conditions tested (proneurals overexpression). Statistical significance (*** - p-value < 
0,01). In all embryos, Cherry protein was used in adjacent sections to identify the 
electroporated side of the spinal cord and as a positive control of the electroporation 
efficiency (A, B and C).  Embryos were harvested 36 hours after electroporation. 
Scale bars: A-F - 50µm. 
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NGN2 overexpression does not affect the number of bHLHB5+LIM3+ cells 
(Fig.11 C-C’’, G), as no differences were detected between sides of the spinal cord 
(n=4, p=0.259507). Furthermore no differences in the bHLHB5+ population were 
detected. 
These observations indicate that overexpression of MASH1 or NGN1 can affect 
the number of prospective V2a inside the V2 domain.  MASH1 overexpression leads to 
a decrease in bHLHB5+LIM3+ progenitors and differentiating CHX10+ V2a. NGN1 
causes also a decrease in bHLHB5+LIM3+ progenitors but an increase in CHX10+ V2a 
INs. These results suggest that while MASH1 “freezes” progenitors in an 
undifferentiated state, NGN1 accelerates neuronal differentiation and causes a 
depletion of progenitors. In contrast, NGN2 not affects the prospective V2a IN 
population. 
 
To determine how overexpression of proneural proteins affects V2b interneuron 
specification, embryos were electroporated with plasmids encoding these proneural 
proteins and harvested 36 hours after electroporation. To identify prospective V2b INs, 
the expression of Scl was analysed, using RNA in-situ hybridization. 
 The results show that MASH1 overexpression causes a decrease in the 
number of Scl+ V2b cells (Fig. 12 A-A’, G). In all embryos analysed, the decrease was 
striking with almost no Scl+ cells in the electroporated side (n=8, p=8.314637e-018).  
NGN1 or NGN2 overexpression, also causes a decrease in the number of Scl+ 
V2b cells (Fig. 12 B-B’ and C-C’, G). This decrease was significant for NGN1 (n=8, 
p=1.449310e-013) and for NGN2 (n=8, p=8.226599e-008). 
 These data point out that all three proneural proteins tested repress the 
prospective V2b IN fate, with MASH1 repression being the strongest one, as almost no 
Scl+ cells could be detected in the electroporated side of the spinal cord. 
In order to dissect for the presence of combinatorial effects in regulation of IN 
specification, MASH1, NGN1 and NGN2 were overexpressed in different combinations. 
When MASH1 was overexpressed with NGN1 a decrease in the number of Scl+ 
cells is observed (Fig. 12 D-D’, G). Simultaneous overexpression of MASH1 and NGN2 
or NGN1 and NGN2 overexpression, causes a decrease in the number of Scl+ V2b 
cells (Fig. 12 E-E’ and F-F’, G). The observed decrease in the Scl+ V2b cell population 
in the electroporated side of the spinal cord was significant for MASH1 and NGN1 (n=3, 
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p=6.615791e-009), for MASH1 and NGN2 (n=3, p=9.457499e-007) and for both NGNs 
(n=3, p=9.495541e-007).  
Overall these results indicate that the three tested proneural proteins repress 
the Scl+ V2b cells. We could not detect an additive effect or proneural proteins function 
as, in none of the simultaneous overexpression conditions we detect a higher 
repression effect than in single overexpression conditions. However the marker used in 
these analyses (Scl) is transiently expressed during V2 cell transitions, so the number 
of V2b cells could be underestimated, as Scl is not a final differentiation marker, as 
CHX10 (V2a analysis).  
Figure 112 – Scl expression after electroporation of Mash1, Ngn1 and Ngn2, single or in combinations. 
(A-A’’) – MASH1 overexpression leads to a decrease in the number of Scl
+
 cells in the V2 domain. (B-B’’) – 
NGN1 overexpression also represses the number of Scl
+
 cells. (C-C’’) – NGN2 overexpression also decreases 
the number of Scl
+
 cells. (D-D’’) – MASH1 together with NGN1 represses Scl
+
 cells within V2 domain. (E-E’’) – 
MASH1 and NGN2 overexpression decreases the number of Scl
+
 cells in the electroporated side of the spinal 
cord. (F-F’’) – Both NGNS overexpressed decrease Scl
+
 cells in the developing spinal cord. (G) – Percentage 
(%) of Scl
+
 cells between sides of the spinal cord in each one of the conditions tested (proneurals 
overexpression). Statistical significance (*** - p-value < 0,01). In all embryos, Cherry protein was used to 
identify the electroporated side of the spinal cord and as a positive control of the electroporation efficiency (A, 
B, C, D, E, and F). Embryos were harvested 36 hours after electroporation. Scale bars: A-F’’ - 50µm. 
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 Proneural genes are affecting Dll4 expression and IN specification inside the V2 
domain. It is known that the correct positioning of spinal cord domains is achieved 
through different morphogen combinations that will establish the DV axis of the spinal 
cord. Neuronal differentiation, in the spinal cord, involves crossregulatory interactions 
between a bHLH-driven program of neurogenesis and genetic pathways of DV 
patterning that specify progenitor and neuronal identity. For instance, it was shown that 
Retinoic acid, via Notch signalling, control the expression of Mash1 and that 
quantitative differences of this transcription factor can select distinct fates 52. 
 Our hypothesis is that overexpression of proneural genes can impose a new 
subtype specification program on progenitors and, therefore, affect the DV specification 
of the spinal cord. We have focused in the MN domain because it was shown that the 
MN domain maintains cross-antagonistic interactions with V2 domain 29. 
 To test this, we analysed the expression of OLIG2, a protein specifically 
expressed in MN progenitors. It was also analysed JAG1 expression, a Notch ligand 
expressed in V1 domain, in order to have an internal control for DV modifications 
between both sides of the spinal cord. Embryos electroporated with plasmids encoding 
these proneural proteins, were analysed for the combined expression of OLIG2 and 
JAG1, using immunofluorescence with appropriate antibodies. 
When MASH1 was overexpressed, an increase in the number of OLIG2+ cells is 
observed (Fig. 13 – A and G), being this increase significant (n=4, p= 0.000812698). 
After NGN1 overexpression, no differences in the OLIG2+ population were 
observed (n=4, p= 0.0760502; Fig. 13 – B and G). NGN2 overexpression does not alter 
the number of OLIG2+ cells (n=3, p= 0.0760502; Fig. 13 – C and G). 
To dissect for the presence of combinatorial effects in regulating DV 
specification, MASH1, NGN1 and NGN2 were overexpressed in different combinations. 
Simultaneous MASH1 and NGN1 overexpression leads to an increase in 
OLIG2+ cells (n=3, p=0.00413902; Fig. 13 – D and G). When MASH1 was 
overexpressed with NGN2 an increase in the OLIG2+ population was noticed (n=3, p= 
0.0407129; Fig. 13 – E and G). When both NGNs were overexpressed, the same trend 
was observed (n=3, p= 0.0165837; Fig. 13 – F and G). 
 These observations indicate that MASH1 is the most effective proneural in 
regulating the number of OLIG2+ cells (MN progenitors). The excess of OLIG2+ cells 
could indicate that these cells are being produced at the expense of V2 progenitors or 
at the expense of fully differentiated V2 INs. MASH1 could be imposing a new subtype 
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Figure 123 - JAG1 and OLIG2 expression after electroporation of Mash1, Ngn1 and Ngn2, single or in 
combinations. (A) – MASH1 overexpression leads to an increase in the OLIG2
+
 cells. (B, C) – NGN1 or NGN2 
overexpression does not alter the number of OLIG2
+
 cells. (D) – MASH1 and NGN1 overexpression increase the 
number of OLIG2
+
 cells. (E) – MASH1 and NGN2 overexpression also increase OLIG2
+
 cells. (F) – NGN1 and 
NGN2 overexpression has the same effect in the OLIG2
+
 population. (G) – Percentage (%) of OLIG2
+ 
cells 
between sides of the spinal cord in each one of the conditions tested (proneurals overexpression). Statistical 
significance (*** - p-value < 0,01; ** - p-value < 0,05). In all embryos, Cherry protein was used in adjacent sections 
to identify the electroporated side of the spinal cord and as a positive control of the electroporation efficiency.  
Embryos were harvested 36 hours after electroporation. (+) – Identification of the electroporated side of the spinal 
cord. Scale bars: A-F - 50µm. 
 
+ + + + 
+ + 
specification program on V2 progenitors and changing their fate towards a MN fate, 
affecting the DV specification of the spinal cord. Simultaneous overexpression of 
proneural genes has the same effect, increasing the number of MN progenitors (pMN). 
 
 
To test whether apoptosis is occurring after electroporation and affects the 
results above described, an antibody against activated caspase 3 was used to detect 
apoptotic cells in adjacent sections of electroporated spinal cords. No significant 
differences were found in the number of apoptotic cells between the electroporated and 
non-electroporated sides of the spinal cord (data not shown), revealing that the 
observed alterations are not due to non-specific apoptotic effects. 
In all analysis, single overexpression of proneural proteins results from an 
average of four sections on six embryos while simultaneous overexpression of 
proneural proteins results from an average of four sections on two or three embryos. 
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 The CNS is a complex system composed by different types of cells however the 
mechanisms responsible for the generation of this cell diversity are not fully 
understood. It is known that Notch signalling is important in this process and this 
project presents new data on how the expression of one Notch ligand, Dll4, is regulated 
and might be involved in IN specification in the V2 domain of the chick developing 
spinal cord. 
 
 In the developing spinal cord, the V2 domain is the only one where two Notch 
ligands are expressed (DLL1 and DLL4). To unravel if Dll1-mediated Notch signalling is 
different than Dll4-mediated Notch signalling, we analysed the expression of two 
different genes (LFng and Hes6). LFng is a potentiator of Notch signalling, while Hes6 
is a Notch signalling target that releases proneural genes from the inhibitory action of 
Hes5.  These genes enable us to see if, in fact, Dll1 and Dll4-mediated Notch signalling 
could be different, in the V2 domain. 
 It is known that a cell starting the differentiation process will have high levels of 
Dll1, thereby activating Notch in neighbours to keep these as progenitors 
(Hes5+LFng+). We show that LFng can be expressed in Dll4-expressing cells in the 
IVZ. We demonstrate that cells that receive Dll4 signalling (and become Scl+ V2b) are 
not expressing LFng, so Notch is activated by Dll4 in Scl+ cells without LFng potentiator 
(Figure 14). Thus, Dll4-mediated Notch signalling is independent of LFng. As described 
previously, Dll1 is keeping the surrounding cells as progenitors, which express LFng, 
so Dll1-mediated Notch signalling is LFng dependent. In the V2 domain, we show that 
Figure 13 – Simplified model of cell transitions in the V2 domain. Dll1-expressing cells express Hes6. 
These cells are starting the differentiation process, keeping the surrounding cells as progenitors (Hes5
+
 
and LFng
+
). The Dll1
+
 cell can upregulate the expression of Dll4, will express Bhlhb5 and then become a 
V2a IN (Chx10
+
), while the Dll4
-
 ones will express Scl and become V2b IN (Gata3
+
). Grey squares 
represent particular steps of these cellular transitions filled by my data. 
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Dll1 and Dll4-mediated Notch signalling are different. We assume that this difference 
could be due to LFng dependence. 
 The analysis of Hes6 expression, a downstream target of Notch signalling, 
shows that it is expressed in Dll1 and Dll4-expressing cells. Since Dll ligands are 
positively regulated by proneural genes, cells that express Dll1 and/or Dll4 should also 
express Hes6 in order to release these proneural genes from the inhibitory action of 
other targets of Notch signalling (Hes5) and therefore differentiate (Figure 14).  
Hes6 may not be a downstream target of Dll4, as it is not expressed in 
prospective V2b INs (Scl-expressing cells), where Notch signalling is activated by Dll4. 
Alternatively Hes6 mRNA could be transient and no longer expressed when Scl 
expression starts. Concerning Dll1, it is known that progenitors activated through Dll1-
mediated Notch signalling can also express Hes6 17, therefore it is possible that Hes6 
is a target of Dll1-mediated Notch signalling. In the V2 domain, Dll1 and Dll4-mediated 
Notch signalling are different. The difference could also rely on Hes6 expression. 
 In summary, my results indicate that Dll1 and Dll4-mediated Notch signalling 
inside the V2 domain occur through different molecular components, as LFng and 
Hes6 are differently expressed in cells where Notch signalling is activate, via Dll1 or 
Dll4. However, further analysis must be made in order to better characterize Dll4-
mediated Notch signalling. Notch signalling activated via Dll4 could be potentiated by 
other members of the Fng family, like MFng (Maniac fringe) or RFng (Radical fringe). 
Also, the difference between Dll1 and Dll4-mediated Notch signalling could rely on 
other downstream targets of this pathway, like other members of the HES family. 
 
Several regions in the Dll4 promoter, conserved between mouse and chicken, 
contain regulatory information for Dll4 expression, as previous results from our lab 
demonstrated 32. The most proximal conserved region contains a Mash1/Brn motif, 
previously identified by Castro et. al 26. This motif is composed by an E-box (CAGCTG) 
and an evolutionary conserved octamer that is the binding site for the POU family of 
homeodomain proteins, such as Brn proteins. Another E-box (CAGGTG) was detected 
and corresponds to the consensus binding sequence for MASH1 32. Furthermore, three 
conserved E-boxes (CAGATG), believed to be preferred for the binding of Neurogenins 
(NGNs), were found 32. These results suggest that MASH1, NGN1 and NGN2 could 
regulate Dll4 expression in the V2 domain of the chick developing spinal cord. 
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 In order to test this, we performed a gain-of-function approach where MASH1, 
NGN1 and NGN2 were overexpressed in the chick developing spinal cord, to measure 
their ability to regulate Dll4 expression.  
 
Table 1 – Results summarized regarding Dll4 expression and IN specification in different conditions (single 
or simultaneous overexpression of proneural proteins). 
  
The results show that MASH1 is able to repress Dll4 expression inside the V2 
domain (Figure 9 – A’, A’’ and summarized inTable1). However, no induction of ectopic 
Dll4 expression was detected (Table 1), contrarily to previous reports 30, 32, 42. This 
discrepancy might be due to the different stages used for electroporation, since 
previous results 30, 32, 42 analysed MASH1 effects on Dll4 at earlier stages (HH19). It is 
possible that the reported ectopic induction of Dll4 is not observed at HH24-25 (stages 
analysed during this project).  
 Concerning the effect of NGN1, our results suggest that it is able to repress Dll4 
expression inside the V2 domain, while it induces ectopic expression in the spinal cord 
(along the DV axis) (Figure 15; Table 1). In contrast, NGN2 overexpression has no 
effect on Dll4 expression, suggesting that this transcription factor is not regulating Dll4 
expression (Figure 15; Table 1). Even though NGN1 and NGN2 are likely to bind to the 
same consensus E-box sequences (CANATG) 9, only NGN1 is able to activate Dll4 
expression.  
 This difference between the two NGNs could be due to specific interactions with 
different co-factors that might affect their transcriptional activity on the Dll4 promoter. 
For instance, in cortical development, LMO4 and its binding partner nuclear LIM 
interactor (NLI/LDB1/CLIM2) form a multi-protein complex with NGN2 that is recruited 
to the E-box that contains enhancers of NGN2-target genes, activating NGN2-mediated 
transcription 53. The reported existence of a strong post-translational control of NGN2 
might also explain why overexpression of this transcription factor has no effect on Dll4 
expression: it has been shown, for example, that phosphorylation of NGN2 differentially 
controls the activation of the NeuroD and Delta promoters by exploiting differences in 
the kinetics of activation in response to promoter occupancy by NGN2 54 55. 
Phosphorylated NGN2 would predominate in rapidly cycling cells, resulting in NGN2 - E 
Condition Mash1 NGN1 NGN2 Mash1+NGN1 Mash1+NGN2 NGN1+NGN2 
Dll4   =   = 
Chx10 (V2a)       
Scl (V2b)       
Ectopic Dll4 No Yes No Yes Yes No 
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Figure 14 – Summary data regarding % of analysed cells for each condition of proneurals 
overexpressed. Each embryo analysed is represented by a symbol: red dots, green squares or blue 
triangles. NE – non-electroporated side of the spinal cord. E – electroporated side of the spinal cord. 
protein dimers with weak promoter affinity. This is insufficient to activate NeuroD 
promoter, however is still able to activate Delta promoter, resulting in non-cell 
autonomous Notch-mediated progenitor maintenance 54. 
 In summary, we show that Dll4 is regulated by MASH1 and NGN1 but not by 
NGN2.  
 If we simply consider the expression pattern of these proneural genes in the V2 
domain, we can distinguish earlier and later phases of expression with a sequential 
action. Mash1 and Ngn1 are expressed in cells closer to the lumen of the spinal cord in 
the IVZ and thus can be considered as “earlier” expressed, while Ngn2 is expressed in 
cells located more basally and it can be considered as a “later” proneural, acting after 
Mash1 and Ngn1.  
 Our data, in mouse embryos, show that Mash1 and Ngn1 are the proneural 
genes that are more co-expressed with Dll4 (79% and 39%, respectively). Due to their 
higher co-expression in Dll4-expressing cells and as early proneural genes, we 
propose that Mash1 and Ngn1 could have a major role in regulating Dll4 expression, 
while Ngn2, as a late proneural gene, could have a major role in V2 IN specification. 
 
 Besides regulating Dll4 expression, it has been shown that MASH1, NGN1 and 
NGN2 can also regulate neuronal specification. For instance Parras et. al 19 and Li et. 
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al 48 have shown that proneural proteins are important for the specification of V2a and 
V2b INs. Since proneural proteins can regulate neuronal subtype specification, we 
analysed if overexpression of MASH1, NGN1 or NGN2 affects the number of V2 INs 
produced.  
 Concerning MASH1 function, our data shows that it can produce a decrease in 
the number of CHX10+ V2a INs and prospective Scl+ V2b INs, in agreement with Li et 
al. 48. Thus, MASH1 is repressing both V2a and V2b IN fate, cell autonomously, as the 
few CHX10+ cells or Scl+ cells that appear in the electroporated side correspond to 
non-electroporated cells (Table 1, Figure 15).  
 Regarding the role of NGN1, it is increasing the number of V2a INs (Table 1, 
Figure 15). As most of the CHX10+ cells correspond to electroporated cells, a possible 
explanation is that misexpressed NGN1 can act cell-autonomously to promote this fate, 
independently of Notch signalling activation in these cells.  
NGN2 overexpression, although it does not alter Dll4 expression, increases the 
number of V2a INs (Table 1, Figure 15). As most of CHX10+ cells correspond to 
electroporated cells, these results suggest that NGN2 is acting cell-autonomously to 
promote the V2a IN fate. Once again, if we consider NGN2 as a late proneural gene, it 
is affecting IN specification without affecting Dll4 expression. 
The results also suggest that single overexpression of either NGN1 or NGN2 is 
decreasing the number of prospective V2b INs. The two NGNs might act cell-
autonomously to repress this fate, as Scl+ cells in the electroporated side correspond to 
non-electroporated cells (Table 1, Figure 15). NGN1 and NGN2 could be accelerating 
differentiation of V2b INs, as few prospective V2b are observed. Another possibility is 
that both NGNs are promoting V2a IN fate at the expense of V2b INs. Further analysis 
of the fully differentiated V2b INs (Gata3+ cells) should be done, in order to validate this 
hypothesis. 
Concerning simultaneous overexpression of proneural proteins, we see that 
NGNs are more efficient in promoting V2a fate as they overcome MASH1 effect (Figure 
15). However, it should be mentioned that the number of embryos analysed was lower 
than in single overexpression conditions. 
After single overexpression of either NGN1 or NGN2, some CHX10+/CHERRY+ 
cells were observed, ventrally to the V2 domain, a position where differentiated V2 INs 
usually migrate to. It is possible that NGN1 and NGN2 are promoting the V2a IN fate, 
causing these cells to prematurely differentiate. Alternatively, NGN1 and NGN2 might 
be inducing ectopic V2a INs in the MN and/or V3 domains. 
Our hypothesis of early and late proneural genes would imply that MASH1 and 
NGN1 (early proneurals) regulate Dll4 expression, while late proneural genes affect 
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just the IN specification. Our results show, indeed, that NGN2, as a later proneural, 
only affect IN specification without affecting Dll4 expression inside the V2 domain. 
 
 The results previously presented show that MASH1 is able to repress Dll4 
expression and, also, the number of V2a and V2b INs. A decrease in the number of 
prospective V2a IN (BHLHB5+LIM3+) was also reported, which supports the observed 
decrease in the number of V2a INs.  Concerning Mash1 overexpression, the number of 
BHLHB5+ cells also decreases in the V2 domain, thus suggesting that MASH1 is 
keeping progenitors in an undifferentiated state.  
We hypothesise that MASH1 misexpression might be keeping progenitors 
proliferative and therefore affects the rate of neurogenesis in this domain. This could 
explain the low number of Dll4+ cells and also V2a and V2b INs, when MASH1 is 
overexpressed. Ultimately this suggests that neurogenesis is happening at a lower rate 
comparing with the non-electroporated side of the spinal cord. To confirm this 
hypothesis, analysis with different neuronal (TUJ1) and progenitor markers (Sox genes 
or Hes5) should be done. 
Previous reports show that MASH1 activates a large number of positive cell cycle 
regulators. Loss-of-function analysis in vivo confirmed that Mash1 plays a major role in 
normal progenitor divisions. So besides regulating early steps of neurogenesis, 
including neuronal commitment, subtype specification and cell cycle exit of progenitors, 
Mash1 can also promote cell proliferation 56. Mash1 is indeed required for normal 
proliferation of neural progenitors in telencephalic development 56 but also in adult 
mouse brain by maintaining subventricular zone cells with long term neurogenic 
potential 57. This function appears to be evolutionarily conserved as Asense, Mash1 
ortholog in Drosophila, also promotes neuroblasts self-renewal 58. To confirm this 
hypothesis, in MASH1 misexpressed embryos, Sox2 (progenitor analysis), Ki67 or 
BrdU injections (proliferation analysis) should be done.  
 Besides MASH1 function in regulating Dll4 expression and IN specification, our 
results show also an increase in the number of OLIG2-positive cells (progenitors of MN 
domain) in MASH1 misexpressed embryos. The increase of OLIG2+ cells could be 
happening at the expense of Scl+ cells. This expansion is similar to what Muroyama et 
al.29 reported in Scl mutants. In this study when Scl is removed, the number of MN 
progenitors is increased. There is a certain degree of plasticity in these progenitor 
populations, as V2b progenitors that normally differentiate into V2b INs can give rise to 
MNs when Scl was deleted. When MASH1 is overexpressed, there could be a shift of 
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progenitors, as the number of MN progenitors (OLIG2+) increases at expense of V2b 
progenitors (less Scl+ cells). 
 Regarding NGN1 overexpression, we see a repression of Dll4 and prospective 
V2b INs while V2a INs are increasing. The number of prospective V2a INs 
(BHLHB5+LIM3+) also decreases, but the overall number of BHLHB5-positive cells 
increases, across domains. Taken together, these results point out to a situation where 
differentiation is accelerated, as more terminally differentiated cells and less 
prospective INs were detected. NGN1 misexpression might be accelerating 
differentiation inside the V2 domain, as more fully differentiated CHX10 V2a INs are 
observed. In fact, proneural proteins have been shown to drive neurogenesis by 
directing the exit of neural progenitors from the cell cycle and promoting the expression 
of proteins, specific from post-mitotic neurons 9. Moreover, proneural proteins capacity 
to direct neuronal differentiation depends on their ability to suppress Sox1-3 expression 
in progenitors 59. Sox1-3 maintains neural progenitor cells in an undifferentiated state 
59. Hence, overexpression of NGN1 might be actively repressing Sox1-3 target genes, 
and progenitor cells are differentiating prematurely. Furthermore the number of Dll4-
positive cells, prospective V2a INs (BHLHB5+LIM3+) and prospective V2b INs (Scl+) is 
lower, probably due to the fact that cells already advanced to differentiation (higher 
number of CHX10+ cells and BHLHB5+ for instance). According to this hypothesis, and 
as described in the previous section, we were able to detect some CHX10+/CHERRY+ 
cells, ventrally to the V2 domain, a position where differentiated V2 INs migrate to. 
Further analysis of both differentiated neurons (Gata3 and TUJ1) and Sox1-3 genes 
should be done in order to validate this hypothesis. 
 Concerning NGN2 overexpression, we observe that it does not alter the number 
of prospective V2a INs (bHLHB5+LIM3+) in the electroporated side, however there is a 
higher number of CHX10+ V2a INs. In this scenario, as a late proneural gene Ngn2 is 
most likely just affecting interneuron specification without accelerating differentiation. 
Once again, NGN2 and NGN1 show different actions, although the two are likely to 
bind to the same consensus E-box sequences (CANATG). One possible explanation 
for this fact can rely on the post-translational control of Ngn2 activity 54 or on the fact 
that NGN2 could need specific co-factors like LMO4 to be transcriptional active. To 
address this hypothesis, double electroporation of NGN2+LMO4 should be done, and 
the analysis of Dll4 expression and prospective V2a (bHLHB5+LIM3+) should be 
repeated in order to see if NGN2 could mimic NGN1 function. 
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The molecular mechanisms by which, in the ventral spinal cord, common 
progenitors differentiate intro different types of interneurons are still poorly unknown. 
This work provides new data and evidences in terms of neurogenesis inside the V2 
domain: the proneural genes Mash1 and Ngn1are acting in earlier steps of cell 
differentiation, regulating Dll4 expression and influencing V2 IN specification while 
Ngn2 regulates later steps of differentiation, acting on V2 IN specification.  
Finally, two different models are proposed for Mash1 and Ngn1 function. Mash1 
is keeping progenitors proliferative while Ngn1 is accelerating neurogenesis.  
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DNA quantification 
One A260 unit corresponds to 50μg/mL of double stranded DNA50. The purity 
of the nucleic acid preparation was estimated by the ratio between the readings 
obtained at 260nm and 280nm (pure preparations of DNA show ratio values of 1.8). 
 
 
 
Table 2 – Probes synthetized with respective linearization site and RNA polymerase 
used. 
Probe Linearization site RNA polymerase 
mHes6 EcoRI T3 
mDll4 BamHI T3 
mLnfng NotI T7 
cScl XbaI T7 
cChx10 XhoI T7 
cDll4 EcoRI T7 
   
 
 
Antibodies used during the course of this work 
  Primary antibodies: sheep anti-Chx10 (Exalpha, 1:100), guinea-pig anti-Bhlhb5 
(kindly provided by Bennett Novitch, UCLA, 1:200), rabbit anti-Lim3 (Abcam, 1:50), 
rabbit anti-Cherry (kindly provided by Adriano Henriques, ITQB, 1:500), rabbit anti-
Olig2 (Millipore, 1:100), goat anti-Jag1 (Santa Cruz, 1:100). 
 Secondary antibodies: donkey anti-sheep (Molecular Probes, 1:400), goat anti-
rabbit (Molecular Probes, 1:400), goat anti-guinea-pig (Molecular Probes, 1:400), 
donkey anti-rabbit (Molecular Probes, 1:400) and donkey anti-goat (Molecular Probes, 
1:400). 
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Table 3 – Composition of all solutions used during this project. 
Solution Composition 
1x TAE Buffer 
 
40mM Tris, 1mM EDTA, 0,35% glacial acetic acid 
Loading Buffer 
 
60% Glycerol (v/v), 10mM EDTA, 0,2% OrangeG (Sigma) 
SOB médium 
 
2% Tryptone, 0,5% Yeast extract, 10mM NaCl, 2.5mM KCl 
Hybridization Buffer 
 
1x Salts, 50% Deionised formamide, 10% Dextran Sulphate, 1mg/ml 
rRNA, 1x Denhardt’s solution 
Washing Solution 
 
1x SSC, 50% Fromamide 
SSC 
 
0.3M Sodium citrate, 3M Sodium chloride, pH 7 
Blocking Reagent 
 
10% Boehringer Blocking Reagent (BBR) in maleic acid buffer 
Antibody Incubator (ISH) 
 
2% blocking reagent and 1% heat-inactivated sheep serum in TBST 
TBST ISH 
 
150mM NaCl, 10mM KCl, 50mM Tris pH 7.5, 0.1% Tween-20 
Mowiol 
 
0.1% Mowiol
®
 (Calbiochem), 33% glycerol, 0.1M Tris pH 8.5 
DAPI 
 
0.15% (w/v) 4’,6-diamidino-2-phenylindole 
TBST Immunohistochemistry 
 
20mM TrisHCl pH 8, 150mM NaCl, 0.05% Tween-20 
  
 
Figure 15 – Controls for Dll4 probe specificity. (A-A’) – Hes6-2:VP16 
electroporated embryos show Dll4 expression in the electroporated cells, 
as expected (positive control). (B) – Endogenous endothelial cells marked 
with Dll4 mRNA probe (white arrows). Scale bars: A-A’ – 50µm; B – 20µm 
